In addition, neonatal G6pt−/− mice were infused intravenously with adenoviral vector containing human G6PT (Ad‐hG6PT) effectively delivered G6pt mRNA to the liver, bone marrow, and spleen and corrected neutropenia as well as myeloid abnormalities.5 This evidence concerns the gene G6PC1 and neutropenia.